Acquisition of Novavax CZ (Tables)

12 Months Ended

Dec. 31, 2022

Business Combination and Asset Acquisition [Abstract]

Schedule of Assets Acquired and Liabilities Assumed

The table below summarizes the final allocation of the purchase price based upon the fair values of assets acquired and liabilities assumed (in thousands):

	May 27, 2020
Prepaid expense and other current assets	$	326
Property and equipment	96,739
Goodwill	70,662
Accounts payable	(1,193)
Accrued expenses	(205)
Other non-current liabilities	(813)
Purchase price, net of cash acquired	$	165,516

Schedule of Business Acquisition, Pro Forma Information

The unaudited pro forma financial information combines the historical results of operations of the Company and Novavax CZ and reflects the application of certain pro forma adjustments (in thousands, except per share amounts):

	Year Ended December 31, 2020
Revenue	$	475,598
Net loss	(419,896)
Basic and diluted net loss per share	$	(7.04)